Literature DB >> 17270362

Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.

Gordana Djordjevic1, Vladimir Mozetic, Danijela Vrdoljak Mozetic, Vanja Licul, Koviljka Matusan Ilijas, Elvira Mustac, Romano Oguic, Zeljko Fuckar, Nives Jonjic.   

Abstract

The purpose of this investigation was to analyze and correlate the immunohistochemical pattern of vascular endothelial growth factor (VEGF) expression with the average of microvessel density (MVD) and other clinicopathologic parameters in clear cell renal cell carcinoma (CCRCC) in order to determine its prognostic significance. Surgical specimens of 93 CCRCC were immunohistochemically analyzed for VEGF expression, MVD with anti-CD31, and Ki 67 proliferative index. VEGF expression was recorded as the percentage of positive tumor cells (<75% and >75%) and as diffuse or perimembranous VEGF expression according to cytoplasmic distribution. Sixty-three (68%) RCC had <75% and 30 had (32%) >75% of VEGF expression. A diffuse cytoplasmic pattern of VEGF expression was found in 61(66%) RCC and a perimembranous one in 32 (34%) RCC. Statistical analysis showed that tumors with >75% of VEGF expression were characterized by lower MVD value (p=0.034), higher nuclear grade (p=0.018), and higher Ki 67 proliferation index (p=0.023). Moreover, a higher nuclear grade of tumor cells was characterized by diffuse cytoplasmic VEGF distribution (p=0.005). This tumor model did not confirm the postulated simple relationship between VEGF overexpression and angiogenesis through high microvessel count. However, the study results indicated that overexpression of VEGF was a worse histologic prognostic parameter in CCRCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270362     DOI: 10.1016/j.prp.2006.12.002

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  14 in total

1.  MR classification of renal masses with pathologic correlation.

Authors:  Ivan Pedrosa; Mary T Chou; Long Ngo; Ronaldo H Baroni; Elizabeth M Genega; Laura Galaburda; William C DeWolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2007-09-26       Impact factor: 5.315

2.  Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.

Authors:  Michalis Liontos; Eleni-Andriana Trigka; Penelope Korkolopoulou; Kimon Tzannis; Giorgos Lainakis; Konstantinos Koutsoukos; Efthymios Kostouros; Maria Lykka; Christos N Papandreou; Vassilis Karavasilis; Christos Christodoulou; Athanasios Papatsoris; Andreas Skolarikos; Ioannis Varkarakis; Ioannis Adamakis; Christos Alamanis; Konstantinos Stravodimos; Dionysios Mitropoulos; Charalambos Deliveliotis; Constantinos A Constantinidis; Angelica Saetta; Efstratios Patsouris; Meletios Α Dimopoulos; Aristotelis Bamias
Journal:  World J Urol       Date:  2016-07-09       Impact factor: 4.226

3.  The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft.

Authors:  Tian-bao Wang; Xiu-qing Wei; Wei-hao Lin; Han-ping Shi; Wen-guang Dong
Journal:  Clin Exp Med       Date:  2011-06-10       Impact factor: 3.984

Review 4.  Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Authors:  George J Netto; Liang Cheng
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

5.  DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma.

Authors:  Koo Han Yoo; Yong-Koo Park; Sung-Goo Chang
Journal:  Oncol Lett       Date:  2012-10-24       Impact factor: 2.967

Review 6.  [Value of targeted therapy for penile cancer].

Authors:  A Heidenreich; D Thüer; D Pfister
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

7.  Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.

Authors:  Wesam M Osman; Nermeen S Youssef
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

8.  Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors.

Authors:  Gordana Djordjević; Koviljka Matusan-Ilijas; Emina Sinozić; Giuseppe Damante; Dora Fabbro; Blazenka Grahovac; Ksenija Lucin; Nives Jonjić
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

9.  Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors.

Authors:  T B Wang; W S Qiu; B Wei; M H Deng; H B Wei; W G Dong
Journal:  Ir J Med Sci       Date:  2009-04-15       Impact factor: 1.568

10.  Antitumor and antiangiogenic activities of anti-vascular endothelial growth factor hairpin ribozyme in human hepatocellular carcinoma cell cultures and xenografts.

Authors:  Li-Hua Li; Zi-Jian Guo; Ling-Ling Yan; Ji-Cheng Yang; Yu-Feng Xie; Wei-Hua Sheng; Zhao-Hui Huang; Xue-Hao Wang
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.